← Back to Search

DASH Diet for High Blood Pressure (DASH4D Trial)

N/A
Waitlist Available
Led By Nisa Maruthur, MD, MHS
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 or older
Diabetes Mellitus Type 2 defined by HbA1c ≥6.5% or treatment of diabetes with diabetes medication(s)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at the end of 5-week feeding period
Awards & highlights

DASH4D Trial Summary

This trial is testing the effects of a DASH-style diet and different sodium levels on blood pressure.

Who is the study for?
Adults with Type 2 Diabetes and blood pressure between 120-159/under 100 mmHg, who can eat on-site meals regularly, have stable weight, no other clinical trials or severe illnesses. Must not be pregnant or planning pregnancy, without significant dietary restrictions that affect adherence.Check my eligibility
What is being tested?
The DASH4D trial is testing the effects of a diabetes-modified DASH diet versus a typical American diet and the impact of low versus high sodium intake on blood pressure in people with Type 2 Diabetes through a controlled feeding study.See study design
What are the potential side effects?
There may not be direct side effects from participating as this trial involves dietary changes rather than medication. However, changes in diet can sometimes cause digestive discomfort or alterations in energy levels.

DASH4D Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have Type 2 diabetes with an HbA1c of 6.5% or higher, or I am on diabetes medication.

DASH4D Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at the end of 5-week feeding period
This trial's timeline: 3 weeks for screening, Varies for treatment, and at the end of 5-week feeding period for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Systolic blood pressure (SBP)
Secondary outcome measures
Cardiovascular disease (CVD) risk percentage
Diastolic blood pressure (DBP)
Fasting glucose level
+11 more

DASH4D Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Comparison diet with higher sodiumExperimental Treatment2 Interventions
Dietary pattern that is typical of what many Americans eat, with sodium level of 3700 mg/day
Group II: DASH4D diet with lower sodiumActive Control2 Interventions
DASH-style dietary pattern, modified for people with diabetes, with sodium level of 1500 mg/day
Group III: DASH4D diet with higher sodiumActive Control2 Interventions
DASH-style dietary pattern, modified for people with diabetes, with sodium level of 3700 mg/day
Group IV: Comparison diet with lower sodiumActive Control2 Interventions
Dietary pattern that is typical of what many Americans eat, with sodium level of 1500 mg/day

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,256 Previous Clinical Trials
14,819,966 Total Patients Enrolled
Beth Israel Deaconess Medical CenterOTHER
836 Previous Clinical Trials
13,010,231 Total Patients Enrolled
Nisa Maruthur, MD, MHSPrincipal InvestigatorJohns Hopkins University

Media Library

DASH4D diet Clinical Trial Eligibility Overview. Trial Name: NCT04286555 — N/A
High Blood Pressure Research Study Groups: DASH4D diet with lower sodium, DASH4D diet with higher sodium, Comparison diet with lower sodium, Comparison diet with higher sodium
High Blood Pressure Clinical Trial 2023: DASH4D diet Highlights & Side Effects. Trial Name: NCT04286555 — N/A
DASH4D diet 2023 Treatment Timeline for Medical Study. Trial Name: NCT04286555 — N/A
High Blood Pressure Patient Testimony for trial: Trial Name: NCT04286555 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings in this research initiative for participants?

"The information available on clinicaltrials.gov states that this study is actively enlisting participants, with the initial posting dating from June 2nd 2021 and most recent update occurring 13 days later."

Answered by AI

How many participants are taking part in this research endeavor?

"Affirmative. Clinicaltrials.gov reveals that this medical trial, which was first posted on June 2nd 2021, is actively looking for participants. It needs to acquire 100 volunteers from a single site."

Answered by AI

Who else is applying?

What state do they live in?
Maryland
California
Pennsylvania
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
0
What site did they apply to?
Johns Hopkins ProHealth

Why did patients apply to this trial?

Hope to reduce or eliminate amount of medication for hbp and diabetes though alternative methods.
PatientReceived 2+ prior treatments
~9 spots leftby Jul 2024